Contact Us

Global HPV Testing And Pap Test Market Report 2025, Forecast To 2034

4 Mar, 2025

How Has The HPV Testing And Pap Test Market Size Evolved Historically?

The hpv testing and pap test market has seen considerable growth due to a variety of factors.
•The market for HPV testing and pap tests has significantly expanded recently. Predictions forecast its growth from $4.4 billion in 2024 to $4.87 billion in 2025, experiencing a compound annual growth rate (CAGR) of 10.6%.
Historic growth in this sector can be credited to initiatives such as cervical cancer awareness drives, the establishment of screening programs, government-backed initiatives and funding, advocacy for women's health, an upsurge in disease prevalence, and practices related to gynecological examinations.

What Will Be The HPV Testing And Pap Test Market Size In The Future?

The hpv testing and pap test market is expected to maintain its strong growth trajectory in upcoming years.
• The market for HPV testing and pap tests is anticipated to experience a significant upsurge in the coming years. This market is projected to expand to "$7.73 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 12.2%.
The surges expected during this forecast period can be credited to factors such as vaccination schemes, precision medicine strategies, the incorporation of molecular diagnostics, global healthy equity efforts, the demographic dynamics of an aging population, and policies on reimbursement for diagnostic tests. Notable trends in this period comprise a tilt towards HPV testing, the simultaneous undertaking of tests, the utilization of molecular testing, the use of automation in testing procedures, and the option for home-based testing.

What Are The Primary Growth Drivers In The HPV Testing And Pap Test Market?

The rise in cervical cancer incidence fuels the growth of the HPV testing and Pap test markets. The unregulated cell growth in the cervix characterizes this particular kind of cancer. Through early detection via HPV testing and Pap tests, this surge in cervical cancer occurrences can be managed. For instance, in January 2023, the US-based American Cancer Society, a volunteer health entity aiming to eradicate cancer, projected that cervical cancer will represent around 13,960 cases within the US. Approximately 4,310 deaths are expected to be related to cervical cancer. Therefore, the escalating instances of cervical cancer are pushing the HPV testing and Pap test market ahead.

What Is The Segmentation Of The Global HPV Testing And Pap Test Market?

The HPV testing and pap test market covered in this report is segmented –
1) By Test Type: HPV Testing, Pap Test
2) By Product: Instruments, Consumables, Services
3) By Technology: Polymerase Chain Reaction (PCR), Immunodiagnostics, Other Technologies
4) By Application: Cervical Cancer Screening, Vaginal Cancer Screening
5) By End User: Hospitals And Clinics, Laboratories, Other End Users Subsegments:
1) By HPV Testing: High-Risk HPV Testing, Low-Risk HPV Testing, HPV Genotyping
2) By Pap Test: Conventional Pap Test, Liquid-Based Pap Test, Pap Plus HPV Testing

Pre-Book The HPV Testing And Pap Test Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:

What Emerging Trends Are Shaping The HPV Testing And Pap Test Market Landscape?

The emergence of product innovations is a significant trend observed in the HPV and Pap test markets. To maintain their market standing, leading companies are launching cutting-edge products. One such example is Yemaachi Biotechnology, a biotech firm in Ghana. In January 2022, they released the Sheba HPV Test, a convenient home sampling system for identifying the human papillomavirus. This widely effective test, which utilizes polymerase chain reaction (PCR) technology, is geared towards finding women who run a high risk of developing cervical cancer.

Who Are the Key Players in the HPV Testing And Pap Test Market?

Major companies operating in the HPV testing and pap test market include:
• Abbott Laboratories
• Qiagen N.V.
• Becton Dickinson and Company
• Quest Diagnostics Inc.
• Hologic Inc.
• F. Hoffmann-La Roche AG
• Femasys Inc.
• Arbor Vita Corporation
• Seegene Inc.
• Thermo Fisher Scientific Inc.
• BioMérieux SA
• Onco Health Corporation
• Takara Bio Inc.
• TruScreen Group Limited
• Danaher Corporation
• Mylab Discovery Solutions Pvt. Ltd.
• Fujirebio Diagnostics Inc.
• Promega Corporation
• Myriad Genetics Inc.
• DiaSorin S.p.A.
• Genomica S.A.U.
• Grifols S.A.
• Illumina Inc.
• Merck & Co. Inc.
• Quidel Corporation
• Randox Laboratories Ltd.
• Siemens Healthineers AG
• Trovagene Inc.
• Vela Diagnostics
• Zymo Research Corp.
• CerviCusco

What are the Regional Insights into the HPV Testing And Pap Test Market?

North America was the largest region in the HPV testing and Pap test market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global HPV testing and Pap tests market report during the forecast period. The regions covered in the HPV testing and pap test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa